Page last updated: 2024-11-07

carbachol and Polycythemia Vera

carbachol has been researched along with Polycythemia Vera in 1 studies

Carbachol: A slowly hydrolyzed CHOLINERGIC AGONIST that acts at both MUSCARINIC RECEPTORS and NICOTINIC RECEPTORS.

Polycythemia Vera: A myeloproliferative disorder of unknown etiology, characterized by abnormal proliferation of all hematopoietic bone marrow elements and an absolute increase in red cell mass and total blood volume, associated frequently with splenomegaly, leukocytosis, and thrombocythemia. Hematopoiesis is also reactive in extramedullary sites (liver and spleen). In time myelofibrosis occurs.

Research Excerpts

ExcerptRelevanceReference
"The isoproterenol effect was blocked by an agent with beta 2 receptor specificity (butoxamine), and L-isomeric configuration (L-propranolol)."1.27Adrenergic modulation of erythropoiesis: in vitro studies of colony-forming cells in normal and polycythaemic man. ( Adamson, JW; Mladenovic, J, 1984)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mladenovic, J1
Adamson, JW1

Other Studies

1 other study available for carbachol and Polycythemia Vera

ArticleYear
Adrenergic modulation of erythropoiesis: in vitro studies of colony-forming cells in normal and polycythaemic man.
    British journal of haematology, 1984, Volume: 56, Issue:2

    Topics: Butoxamine; Carbachol; Cells, Cultured; Colony-Forming Units Assay; Dose-Response Relationship, Drug

1984